RBBP6 Interacts with Multifunctional Protein YB-1 through Its RING Finger Domain, Leading to Ubiquitination and Proteosomal Degradation of YB-1

Journal of Molecular Biology

Volumn 384, Issue 4, 2008, Pages 908-916

  Chibi, Moredreck ^a   Meyer, Mervin ^a   Skepu, Amanda ^c   G Rees, D Jasper ^a   Moolman Smook, Johanna C ^b   Pugh, David J R ^a  

^a UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

proteosome; RBBP6; RING finger; ubiquitination; YB 1

Indexed keywords

BINDING PROTEIN; RETINOBLASTOMA BINDING PROTEIN 6; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DRUG TARGETING; IMMUNOPRECIPITATION; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RING FINGER MOTIF; TRANSACTIVATION; UBIQUITINATION; YEAST;

EID: 56249103765     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.09.060     Document Type: Article

References (23)

1. Pugh D.J., Ab E., Faro A., Lutya P.T., Hoffmann E., and Rees D.J. DWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA processing and ubiquitin-like pathways. BMC Struct. Biol. 6 (2006) 1
2. Simons A., Melamed-Bessudo C., Wolkowicz R., Sperling J., Sperling R., Eisenbach L., and Rotter V. PACT: cloning and characterization of a cellular p53 binding protein that interacts with Rb. Oncogene 14 (1997) 145-155
3. Witte M.M., and Scott R.E. The proliferation potential protein-related (P2P-R) gene with domains encoding heterogeneous nuclear ribonucleoprotein association and Rb1 binding shows repressed expression during terminal differentiation. Proc. Natl Acad. Sci. USA 94 (1997) 1212-1217
4. Sakai Y., Saijo M., Coelho K., Kishino T., Niikawa N., and Taya Y. cDNA sequence and chromosomal localization of a novel human protein, RBQ-1 (RBBP6), that binds to the retinoblastoma gene product. Genomics 30 (1995) 98-101
5. Yoshitake Y., Nakatsura T., Monji M., Senju S., Matsuyoshi H., Tsukamoto H., et al. Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis. Clin. Cancer Res. 10 (2004) 6437-6448
6. Scott R.E., Giannakouros T., Gao S., and Peidis P. Functional potential of P2P-R: a role in the cell cycle and cell differentiation related to its interactions with proteins that bind to matrix associated regions of DNA?. J. Cell. Biochem. 90 (2003) 6-12
7. Gao S., Witte M.M., and Scott R.E. P2P-R protein localizes to the nucleolus of interphase cells and the periphery of chromosomes in mitotic cells which show maximum P2P-R immunoreactivity. J. Cell. Physiol. 191 (2002) 145-154
8. Gao S., and Scott R.E. P2P-R protein overexpression restricts mitotic progression at prometaphase and promotes mitotic apoptosis. J. Cell. Physiol. 193 (2002) 199-207
9. Li L., Deng B., Xing G., Teng Y., Tian C., Cheng X., et al. PACT is a negative regulator of p53 and essential for cell growth and embryonic development. Proc. Natl Acad. Sci. USA 104 (2007) 7951-7956
10. Lasham A., Moloney S., Hale T., Homer C., Zhang Y.F., Murison J.G., et al. The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor. J. Biol. Chem. 278 (2003) 35516-35523
11. Henglein B., Chenivesse X., Wang J., Eick D., and Brechot C. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc. Natl Acad. Sci. USA 91 (1994) 5490-5494
12. Kloks C.P.A.M., Spronk C.A.E.M., Lasonder E., Hoffmann A., Vuister G.W., Grzesiek S., and Hilbers C.W. The solution structure and DNA-binding properties of the cold-shock domain of the human Y-box protein YB-1. J. Mol. Biol. 316 (2002) 317-326
13. Evdokimova V., Ovchinnikov L.P., and Sorensen P.H. Y-box binding protein 1: providing a new angle on translational regulation. Cell Cycle 5 (2006) 1143-1147
14. Okamoto T., Izumi H., Imamura T., Takano H., Ise T., Uchiumi T., et al. Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression. Oncogene 19 (2000) 6194-6202
15. Kohno K., Izumi H., Uchiumi T., Ashizuka M., and Kuwano M. The pleiotropic functions of the Y-box-binding protein, YB-1. BioEssays 25 (2003) 691-698
16. Rethinasamy P., Muthuchamy M., Hewett T., Boivin G., Wolska B.M., Evans C., et al. Molecular and physiological effects of alpha-tropomyosin ablation in the mouse. Circ. Res. 82 (1998) 116-123
17. Lutz M., Wempe F., Bahr I., Zopf D., and von M.H. Proteasomal degradation of the multifunctional regulator YB-1 is mediated by an F-box protein induced during programmed cell death. FEBS Lett. 580 (2006) 3921-3930
18. Homer C., Knight D.A., Hananeia L., Sheard P., Risk J., Lasham A., et al. Y-box factor YB1 controls p53 apoptotic function. Oncogene 24 (2005) 8314-8325
19. Raffetseder U., Frye B., Rauen T., Jurchott K., Royer H.D., Jansen P.L., and Mertens P.R. Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J. Biol. Chem. 278 (2003) 18241-18248
20. Filion G.J.P., Zhenilo S., Salozhin S., Yamada D., Prokhortchouk E., and Defossez P.A. A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol. Cell. Biol. 26 (2006) 169-181
21. Kwon J.E., La M., Oh K.H., Oh Y.M., Kim G.R., Seol J.H., et al. BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase. J. Biol. Chem. 281 (2006) 12664-12672
22. Fujii T., Yokoyama G., Takahashi H., Namoto R., Nakagawa S., Toh U., et al. Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer. Breast Cancer 15 (2008) 73-78
23. Yang F., Peng Y., Murray E.L., Otsuka Y., Kedersha N., and Schoenberg D.R. Polysome-bound endonuclease PMR1 is targeted to stress granules via stress-specific binding to TIA-1. Mol. Cell. Biol. 26 (2006) 8803-8813